Cutting edge technology-based drug delivery systems have been rapidly growing and are being applied to various sections of biomedicine. The current scenario of global burden due to infectious disorders can take advantage of nanoparticulate based carriers to advance the cure efficiency. Nanostructured Drug Delivery Systems in Infectious Disease Treatment explores a broad range of promising approaches for the treatment of infectious diseases using the latest advancements in nanomedical technologies.
The book opens with introduction about infectious diseases and its global burden. There is also specific discussion and assessment of the global impact of viruses with an emphasis on COVID-19, Zika, and Ebola. Subsequent chapters provide detailed information about various novel nanotherapeutic strategies used for delivering drugs for the treatment of various types of viral, bacterial, and fungal disorders. Nanostructured Drug Delivery Systems in Infectious Disease Treatment is a valuable resource for graduates, researchers, industry professionals, and anyone working to tackle the challenges of delivering drugs in a more targeted and efficient manner for the treatment of infectious diseases.
- Focuses on the application of different nanotechnology-based drug delivery systems
- Offers information on how to design and develop the nanotechnology-based drug delivery systems and devices for the treatment of infectious disorders
- Explores challenges and regulatory concerns of nanomedicine in infectious disorders
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-443-13336-7 (9780443133367)
Schweitzer Klassifikation
1. Introduction to infectious diseases and its global burden2. Impact assessment of virus globally: Special emphasis on COVID-19, Zika and Ebola virus3. Nano combinatorial therapies for infectious disorders4. Stimuli responsive nanotechnological advancements in infectious disorders5. Application of nanotechnology-based therapy against malaria6. Therapeutic potential of nano assisted delivery in tuberculosis and its management7. Exploration of advanced therapeutics for lymphatic and cutaneous leishmania8. Nanotechnological driven chemotherapy for treatment of fungal infections9. Nanoantibiotics driven approaches as advanced therapy for bacterial infections and chemotherapeutic resistance10. Role of biotechnology as theranostic tool in infectious diseases11. Nanovesicles as advanced tool against infectious diseases12. Role of nanotechnology derived natural product as potential therapeutics against infectious diseases13. Nanovaccines as futuristic tool to eradicate infectious diseases14. Nanotechnology and resistance against biofilm15. Nanotherapeutics in counteracting brain infection16. Nanomedicine in infectious disorders: Challenges and regulatory concerns
